Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples